glp/gip/glucagon & cagrilintide Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit GIPR/GLP-1R dual agonist therapies for

Prevention: administer for 2 consecutive days

View drip The Spartan For: athletes, active recovery Athletic recovery and muscle hydration

Perdomo-Celis F, Salgado DM, Castaeda DM, Narvez CF

No, traditional lipotropic fat burner shots do not contain GLP-1 medications

The FDA is responding to the science, the demand, and the voices of practitioners who have been advocating for safer, more transparent access

KPV is derived from alpha-MSH and has been studied for: Inflammatory modulation Gut barrier support Immune regulation Reduction in inflammatory cytokines Why KPV May Help Rosacea Because rosacea is heavily linked to inflammatory and gut-immune dysfunction, KPV may support: Reduction of inflammatory signaling Improved gut-skin communication Barrier repair Immune balance This may be especially useful in rosacea patients who also experience: Digestive symptoms Food sensitivities Histamine intolerance Inflammatory bowel issues How GLOW May Support Rosacea Recovery The GLOW framework combines: These peptides are often discussed for: Tissue healing Inflammatory support Collagen signaling Skin recovery GHK-Cu and Skin Remodeling GHK-Cu is especially relevant because it has been associated with: Collagen support Skin repair Antioxidant activity Improved skin appearance Rosacea frequently impairs skin integrity over time